secwatch.observer — SEC 8-K summary
======================================

Issuer:     IGC Pharma, Inc. (IGC)
CIK:        0001326205
Form:       8-K
Filed at:   2026-01-02T23:59:59+00:00
Accession:  0001185185-26-000010
Event type: other
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.03
LLM model:  deepseek-v4-flash:cloud@v2

IGC Pharma changes fiscal year-end from March 31 to December 31, effective 2025
-------------------------------------------------------------------------------

- Board approved fiscal year change from March 31 to December 31, effective Dec 31, 2025.
- Company will file a Transition Report on Form 10-K for the nine-month period April 1 to Dec 31, 2025.
- Future fiscal years will end on December 31, aligning with the calendar year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326205/000118518526000010/0001185185-26-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326205/000118518526000010/igc8k010226.htm
  HTML page:      https://secwatch.observer/filing/0001185185-26-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer